openPR Logo
Press release

Insomnia Treatment Market to Hit US$ 11.39 Billion by 2034, Growing at a CAGR of 5.2%

05-23-2025 03:47 PM CET | Health & Medicine

Press release from: FactMR

Insomnia Treatment Market to Hit US$ 11.39 Billion by 2034,

The global insomnia treatment market is expected to be worth US$ 6,886.1 million in 2024. The market is anticipated to expand at a CAGR of 5.2% from 2024 to 2034. The market is predicted to reach US$ 11,385.5 million in 2034. Increasing awareness and understanding of the condition among patients and healthcare professionals is one of the key drivers of the insomnia treatment industry.

As more people come to recognize the impact that insomnia has on their daily lives, they are seeking out treatments to help manage their symptoms. Additionally, advances in medical research and technology have led to the development of more effective and targeted treatments for insomnia. This has allowed healthcare providers to offer patients a wider range of options for managing their condition, from medication to behavioral therapies.

The changes in lifestyle and work patterns have contributed to the rise of insomnia, as many people find themselves struggling to balance their responsibilities with the need for restful sleep. As such, there is a growing need for effective and accessible treatments to help people manage their insomnia and improve their overall quality of life.

For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=9613

Key Market Drivers

Rising Prevalence of Sleep Disorders: Lifestyle changes, increased stress levels, and work-related pressures have contributed to a surge in insomnia cases globally. As more individuals recognize the importance of quality sleep, the demand for treatment options has escalated .
Advancements in Therapeutic Options: The development of novel pharmacological treatments, such as dual orexin receptor antagonists, offers more targeted and effective solutions for insomnia with fewer side effects compared to traditional sedatives .
Growth of Over-the-Counter (OTC) Medications: OTC drugs are gaining popularity due to their accessibility and cost-effectiveness. In 2024, OTC drugs are expected to account for a significant share of the market, driven by consumer preference for easily obtainable sleep aids .

Regional Insights

North America: This region holds a substantial share of the insomnia treatment market, attributed to high awareness levels, robust healthcare infrastructure, and the adoption of digital health tools. The U.S., in particular, faces a significant economic burden due to inadequate sleep, emphasizing the need for effective treatment options .
Asia-Pacific: Countries like India, China, and Japan are experiencing rapid growth in the insomnia treatment market. Factors such as urbanization, increased screen time, and rising mental health concerns contribute to this trend. In India, for instance, the market is expected to grow at a CAGR of 2.57% from 2025 to 2033, driven by increased stress levels and growing awareness about sleep disorders .

Emerging Trends

Digital Therapeutics: The integration of digital solutions, such as mobile applications and wearable devices, is revolutionizing insomnia treatment. These tools offer personalized therapy options, including cognitive behavioral therapy for insomnia (CBT-I), and have shown a 70% success rate in improving sleep quality
Non-Pharmacological Treatments: There's a growing preference for non-drug therapies, including CBT and relaxation techniques, due to concerns over the side effects of long-term medication use. These approaches are gaining traction as effective alternatives for managing insomnia .

Challenges

Despite the positive outlook, the market faces challenges such as side effects associated with certain insomnia medications, which can hamper long-term treatment adherence. Additionally, the need for more personalized treatment approaches remains a critical area for development.

Get Customization on this Report for Specific Research Solutions-https://www.factmr.com/connectus/sample?flag=S&rep_id=9613

Conclusion

The insomnia treatment market is undergoing significant transformation, driven by increased awareness, technological advancements, and a shift towards personalized and non-pharmacological therapies. As the understanding of sleep disorders deepens, the market is expected to continue its growth trajectory, offering diverse and effective treatment options for individuals worldwide.

Explore More Related Studies Published by Fact.MR Research:

Dental Infection Control Products Market

https://www.factmr.com/report/5378/dental-infection-control-products-market

Air Ambulance Services Market

https://www.factmr.com/report/air-ambulance-services-market

Neonatal Ventilator Market

https://www.factmr.com/report/758/neonatal-ventilator-market

Dental 3D Printing Market

https://www.factmr.com/report/4361/dental-3d-printing-market

Joint Reconstruction Devices Market

https://www.factmr.com/report/joint-reconstruction-devices-market

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insomnia Treatment Market to Hit US$ 11.39 Billion by 2034, Growing at a CAGR of 5.2% here

News-ID: 4033872 • Views:

More Releases from FactMR

Invisible Orthodontics Market Set to Reach US$ 4 Billion in 2024, Poised for 5.2% CAGR Growth Through 2034
05-23-2025 | Health & Medicine
FactMR
Invisible Orthodontics Market Set to Reach US$ 4 Billion in 2024, Poised for 5.2 …
The invisible orthodontics market size is forecasted to hit US$ 4,001.2 million in 2024. A promising compound annual growth rate (CAGR) of 5.2% is projected to boost the market consistently through 2034. This upward motion is estimated to lead the market to a significant valuation of US$ 6,648.7 million by 2034. The World Health Organization (WHO) emphasizes that good oral health is a key indicator of overall well-being, happiness, and quality
Ineffective Esophageal Motility Treatment Market to Reach US$ 8.08 Billion by 2034, Driven by 6.1% CAGR Fact.MR Analysis
05-23-2025 | Health & Medicine
FactMR
Ineffective Esophageal Motility Treatment Market to Reach US$ 8.08 Billion by 20 …
The global ineffective esophageal motility treatment market is estimated to be worth US$ 4,488.8 million in 2024. The market is expected to register a CAGR of 6.1% from 2024 to 2034. The market is set to reach a projected value of US$ 8,080.7 million by 2034. The global market for treating ineffective esophageal motility is witnessing key trends driven by advancements in diagnostic technologies, a shift toward personalized medicine, and innovations
Global Liquid Sodium Silicate Market to Hit US$ 5.78 Billion by 2034, Growing at 4.3% CAGR
Global Liquid Sodium Silicate Market to Hit US$ 5.78 Billion by 2034, Growing at …
The global liquid sodium silicate market has been projected at a value of US$ 3.65 billion for 2024 and is forecasted to reach a size of US$ 5.78 billion by the end of 2034. The market is projected to expand at a CAGR of 4.3% from 2024 to 2034. Liquid sodium silicate, often known as water glass, is a colorless, odorless, and viscous chemical created by melting high-purity sand with sodium
Hydrogen Sensor Market in East Asia to Reach US$ 121 Million by 2034, Expanding at 6.8% CAGR
Hydrogen Sensor Market in East Asia to Reach US$ 121 Million by 2034, Expanding …
Fact.MR, in its newly published report, reveals that sales of hydrogen sensors in East Asia are pegged at US$ 62.6 million for 2024. The market in East Asia is projected to rise at 6.8% CAGR and reach a size of US$ 121 million by the end of 2034. Countries in East Asia are focusing on developing a hydrogen economy. This has led to the increasing use of hydrogen as a renewable

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current